<!DOCTYPE HTML>
<html lang="ru">
<head>
	<meta charset="utf-8">
	<title>Final-task</title>
	<link rel="stylesheet" href="stylesheets/style.css">
</head>
<body>
    <div class="wrapper">
        <header>
            <nav>
                <ul>
                    <li class="nav-tab">
                        <button class="nav-tab-item nav-tab-item-active">Graphics</button>
                    </li>
                    <li class="nav-tab">
                        <button class="nav-tab-item">Calculator</button>
                    </li>
                        <li class="nav-tab">
                            <button class="nav-tab-item">Competitors</button>
                        </li>
                </ul>
            </nav>
        </header>
        <section class="page slider-active">
            <h1 class="graphics-header">Xarelto<sup>®</sup>: An Effective Treatment Option <br> in Your VTE Patients with Cancer<sup>a,8</sup></h1>
            <p class="graphics-name-axis-y">% PATIENTS<sup>b</sup></p>
            <div class="graphics-table">
                <ul class="graphics-axis-number">
                    <li>8 —</li>
                    <li>7 —</li>
                    <li>6 —</li>
                    <li>5 —</li>
                    <li>4 —</li>
                    <li>3 —</li>
                    <li>2 —</li>
                    <li>1 —</li>
                    <li>0</li>
                </ul>
                <p class="graphics-table-title">HR 0.69;<br>95% CI 0.36-1.33</p>
                <div class="graphics-column-blue">
                    <p class="graphics-column-text-top">7.1<br>n=20/281</p>
                    <p class="graphics-column-text-bottom">ENOXAPARIN / VKA</p>
                </div>
                <div class="graphics-column-red">
                    <p class="graphics-column-text-top">5.1<br>n=20/281</p>
                    <p class="graphics-column-text-bottom">XALERTO</p>
                </div>
                <div class="graphics-hr">
                </div>
                <p class="graphics-name-axis-x-for-zero">0</p>
                <p class="graphics-name-axis-x-for-cancer">Cancer</p>
            </div>
            <img class="graphics-person" src="assets/images/graphics/person.png" alt="person">
            <p class="graphics-footer-text"><sup>a</sup>Xarelto is contraindicated in lesions or conditions, 
                if they are considered to be a significant risk for major<br>
                bleeding, which may include the presence of malignant neoplasms at high risk of bleeding.<br>
                <sup>b</sup>Outcome: symptomatic, recurrent VTE.</p>
        </section>
        <section class="page">
            <h1 class="graphics-header">Xarelto<sup>®</sup> Estimator of Resources Saved</h1>
            <div class="calculator-block">
                <div class="calculator-block-left">
                    <dl class="calculator-input-number">
                        <dt class="calculator-input-number-block">
                            <input type="text" placeholder="Enter number of DVT patients here" data-bind="value: enterNumberLeft">
                            <input type="button" value="CALCULATE" class="calculator-input-number-calculate" data-bind="click: calculateAll">
                            <input type="button" value="?" class="calculator-input-number-quest">
                        </dt>
                        <dd class="calculator-input-number-block-bottom">
                            <p class="calculator-input-number-block-bottom-text">
                                Assumptions to estimate calculations: proportion of patients whit DVT contraindicated for
                                Xarelto or LMWH/VKA<sup>1,2</sup> =7.5%<br>
                                <b>Number of patients with DVT - 7.5% =<span data-bind="text: NumberOfPatientsWithDVT"> [A]</span></b> 
                                Total number of DVT patients eligible for dual LMWH/VKA or Xarelto
                            </p>
                        </dd>
                    </dl>
                    <dl class="calculator-block-value">
                        <dt class="calculator-block-value-header">
                            <p>Injections avoided<sup>3-7</sup></p>
                            <input type="text" value="[B + C]" data-bind="value: InjectionsAvoidedCalculationleft">
                        </dt>
                        <dd class="calculator-block-value-footer">
                            <button class="calculator-block-value-footer-add">+</button>
                            <p>Injections Avoided = number ofg LMWH injections received by cancer patients with DVT + LMWH
                                injections received by DVT patients without cancer
                            </p>
                        </dd>
                    </dl>
                    <dl class="calculator-block-value">
                        <dt class="calculator-block-value-header">
                            <p>INR clinic visits avoided <sup>3,7,8</sup></p>
                            <input type="text" value="[E]" data-bind="value: InrClinicVisitsAvodedLeft">
                        </dt>
                        <dd class="calculator-block-value-footer">
                            <button class="calculator-block-value-footer-add">+</button>
                            <p>INR clinic visits avoided = number of DVT patients eligible for VKA treatment x number of
                                INR monitoring visits per patient
                            </p>
                        </dd>
                    </dl>
                    <dl class="calculator-block-value">
                        <dt class="calculator-block-value-header">
                            <p>Nurse visits avoided<sup>9</sup></p>
                            <input type="text" value="[G]" data-bind="value: NurseVisitsAvoidedLeft">
                        </dt>
                        <dd class="calculator-block-value-footer">
                            <button class="calculator-block-value-footer-add">+</button>
                            <p>Nurse assistanse visits avoided = number of non-cancer DVT patients eligible
                                for initial LMWH treatment x proportion of these patients treated by nurses
                                in their own homes x mean number of LMWH injections administered
                            </p>
                        </dd>
                    </dl>
                    <dl class="calculator-block-value">
                        <dt class="calculator-block-value-header">
                            <p>Hospital bed days saved<sup>10</sup></p>
                            <input type="text" value="[H]" data-bind="value: HospitalBedDaysSavesLeft">
                        </dt>
                        <dd class="calculator-block-value-footer">
                            <button class="calculator-block-value-footer-add">+</button>
                            <p>Hospital bed days saved = number of eligible DVT patients x proportion
                                of DVT patients hospitalised x number of hospital bed days per DVT patient treated with Xarelto
                            </p>
                        </dd>
                    </dl>
                </div>
                <div class="calculator-block-right">
                    <div class="enter-number">
                        <dt class="calculator-input-number-block">
                            <input type="text" placeholder="Enter number of patients with PE here" data-bind="value: enterNumberRight">
                            <input type="button" value="CALCULATE" class="calculator-input-number-calculate" data-bind="click: calculateAll">
                            <input type="button" value="?" class="calculator-input-number-quest">
                        </dt>
                        <dd class="calculator-input-number-block-bottom">
                            <p class="calculator-input-number-block-bottom-text">
                                Assumptions to estimate calculations: proportion of patients whit PE contraindicated
                                 for Xarelto or LMWH/VKA<sup>1,2</sup> = 15%<br>
                                <b>Number of patients with PE - 15% = <span data-bind="text: NumberOfPatientsWithDVTRight">[A]</span></b>
                                Total number of PEv patients eligible for dual LMWH/VKA or Xarelto
                            </p>
                        </dd>
                    </div>
                    <dl class="calculator-block-value">
                        <dt class="calculator-block-value-header">
                            <p>Injections avoided<sup>3-6,11</sup></p>
                            <input type="text" value="[B + C]" data-bind="value: InjectionsAvoidedCalculationRight">
                        </dt>
                        <dd class="calculator-block-value-footer">
                            <button class="calculator-block-value-footer-add">+</button>
                            <p>Injections Avoided = number of LMWH injections received by cancer patients with
                                PE + LMWH injections received by PE patients without cancer
                            </p>
                        </dd>
                    </dl>
                    <dl class="calculator-block-value">
                       <dt class="calculator-block-value-header">
                            <p>INR clinic visits avoided <sup>3,8,11</sup></p>
                            <input type="text" value="[I]" data-bind="value: InrClinicVisitsAvodedRight">
                        </dt>
                        <dd class="calculator-block-value-footer">
                            <button class="calculator-block-value-footer-add">+</button>
                            <p>INR clinic visits avoided = number of PE patients eligible for VKA treatment
                                x number of INR monitoring visits per patient
                            </p>
                        </dd>
                    </dl>
                    <dl class="calculator-block-value">
                        <dt class="calculator-block-value-header">
                            <p>Hospital bed days saved<sup>10</sup></p>
                            <input type="text" value="[J]" data-bind="value: HospitalBedDaysSavesRight">
                        </dt>
                        <dd class="calculator-block-value-footer">
                            <button class="calculator-block-value-footer-add">+</button>
                            <p>Hospital bed days saved = number of eligible PE patients x proportion of PE
                                patients hospitalised x number of hospital bed days per PE patient treated with Xarelto
                            </p>
                        </dd>
                    </dl>
                </div>
                <div class="calculator-block-footer">
                    <div class="calculator-block-footer-top">
                        <p>Combined DVT + PE Resour Saved</p>
                    </div>
                    <div class="calculator-block-footer-item">
                        <p>Injections avoided <sup>3-7,11</sup></p>
                        <input type="text" value="[DVT+PE]" data-bind="value: NurseVisitsAvoidedDVT">
                    </div>
                    <div class="calculator-block-footer-item">
                        <p>INR clinic visits avoided<sup>3,7,8,11</sup></p>
                         <input type="text" value="[DVT+PE]" data-bind="value: InrClinicVisitsAvodedDVTPE">
                    </div>
                    <div class="calculator-block-footer-item">
                        <p>Nurse visit avoided<sup>9</sup></p>                        
                        <input type="text" value="[DVT]" data-bind="value: InjectionsAvoidedDVTPE">                        
                    </div>
                    <div class="calculator-block-footer-item">
                        <p>Hospital bed days saved<sup>10</sup></p>                        
                        <input type="text" value="[DVT+PE]" data-bind="value: HospitalBedDaysSavesDVTPE">                        
                    </div>
                </div>
            </div>
            <p class="graphics-footer-text competitors-scales-footer-text"><sup>a</sup>Xarelto is contraindicated
                in lesions or conditions, 
                if they are considered to be a significant risk for major bleeding, which may include the presence<br>
                of malignant neoplasms at high risk of bleeding. <sup>b</sup>Outcome: symptomatic, recurrent VTE.
            </p>
        </section>
        <section class="page">
            <h1 class="graphics-header competitors-header">Xarelto® DVT Patients Reported Higher Satisfaction<sup>a,16</sup> 
            </h1>
            <div class="competitors-scales">
                <div class="competitors-double-sided-arrow">
                    <p class="competitors-double-sided-arrow-higher">Higher Preference</p>
                    <figure class="competitors-vertical-hr">
                    </figure>
                    <p class="competitors-double-sided-arrow-higher competitors-double-sided-arrow-lower">Lower Preference</p>                
                </div>
                <div class="competitors-scales-block">
                    <div class="competitors-scales-header-hr">                    
                    </div>
                    <div class="competitors-scales-left-bowl">
                        <p class="competitors-scales-left-text">80.8</p>
                    </div> 
                    <div class="competitors-scales-stand">
                        
                    </div> 
                    <div class="competitors-scales-stand-footer">
                        <p>p&lt;0.0001</p>                                       
                    </div>
                    <p class="competitors-scales-footer">Global Satisfaction<sup>b</sup></p>
                    <div class="competitors-scales-left-bowl competitors-scales-right-bowl">
                        <p class="competitors-scales-left-text">72.7</p>
                    </div>             
                </div>
                <div class="competitors-scales-right-link">
                    <div class="competitors-scales-right-top-link">
                        <figure class="competitors-scales-right-link-square">
                            
                        </figure>
                        <button class="competitors-scales-right-link-text">Xarelto (N=702)
                        </button>  
                    </div>
                    <div class="competitors-scales-right-bottom-link">
                        <figure class="competitors-scales-right-link-square competitors-scales-right-link-square-red">
                            
                        </figure>
                        <button class="competitors-scales-right-link-text">Enoxaparin/VKA (N=677)
                        </button>  
                    </div>                   
                </div>
            </div>
            <div class="footer-square-for-competitors-scales">
                <p>TSQM II <br>Global <br>Satisfaction</p>
            </div>
            <p class="graphics-footer-text competitors-scales-footer-text"><sup>a</sup>Xarelto is contraindicated in lesions or conditions, 
                if they are considered to be a significant risk for major<br>
                bleeding, which may include the presence of malignant neoplasms at high risk of bleeding.<br>
                <sup>b</sup>Outcome: symptomatic, recurrent VTE.
            </p>
        </section>
    </div>
    <script src="scripts/knockout-3.1.0.js"></script>
    <script src="scripts/tab-slider.js"></script> 
    <script src="scripts/calculator.js"></script>   
</body>
</html>